UBS AM’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-31,713
| Closed | -$855K | – | 2744 |
|
2022
Q4 | $855K | Sell |
31,713
-730
| -2% | -$19.7K | ﹤0.01% | 1924 |
|
2022
Q3 | $583K | Buy |
32,443
+1
| +0% | +$18 | ﹤0.01% | 2280 |
|
2022
Q2 | $403K | Hold |
32,442
| – | – | ﹤0.01% | 2381 |
|
2022
Q1 | $432K | Hold |
32,442
| – | – | ﹤0.01% | 2506 |
|
2021
Q4 | $505K | Hold |
32,442
| – | – | ﹤0.01% | 2558 |
|
2021
Q3 | $728K | Hold |
32,442
| – | – | ﹤0.01% | 2325 |
|
2021
Q2 | $739K | Buy |
32,442
+2,812
| +9% | +$64K | ﹤0.01% | 2365 |
|
2021
Q1 | $610K | Sell |
29,630
-10,163
| -26% | -$209K | ﹤0.01% | 2319 |
|
2020
Q4 | $1.1M | Buy |
39,793
+4,447
| +13% | +$123K | ﹤0.01% | 1942 |
|
2020
Q3 | $497K | Sell |
35,346
-13,603
| -28% | -$191K | ﹤0.01% | 2147 |
|
2020
Q2 | $1.01M | Buy |
48,949
+23,106
| +89% | +$476K | ﹤0.01% | 1802 |
|
2020
Q1 | $195K | Sell |
25,843
-3,847
| -13% | -$29K | ﹤0.01% | 2285 |
|
2019
Q4 | $461K | Buy |
+29,690
| New | +$461K | ﹤0.01% | 2269 |
|